| |
| |
|
| Insider
Information: |
Adjuvant Capital Management, Llc |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,995,958 |
|
|
Indirect Shares
|
377,542 |
|
|
| Direct
Value |
$4,690,501 |
|
|
|
Indirect Value
|
$887,224 |
|
|
| Total
Shares |
2,373,500 |
|
|
| Total
Value |
$5,577,725 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
An2 Therapeutics Ord Shs |
ANTX |
|
2024-01-16 |
1,995,958 |
2024-01-16 |
377,542 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2024-01-16 |
4 |
S |
$19.65 |
$312,573 |
I/I |
(15,907) |
377,542 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2024-01-16 |
4 |
S |
$19.65 |
$1,652,427 |
D/D |
(84,093) |
1,995,958 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-11-14 |
4 |
AS |
$16.15 |
$4,650 |
I/I |
(288) |
393,449 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-11-14 |
4 |
AS |
$16.15 |
$24,574 |
D/D |
(1,522) |
2,080,051 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-10-02 |
4 |
AS |
$16.07 |
$14,495 |
I/I |
(902) |
393,737 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-10-02 |
4 |
AS |
$16.07 |
$76,654 |
D/D |
(4,770) |
2,081,573 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-29 |
4 |
AS |
$16.28 |
$1,356,726 |
D/D |
(83,337) |
2,086,343 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-29 |
4 |
AS |
$16.28 |
$256,638 |
I/I |
(15,764) |
394,639 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-28 |
4 |
AS |
$16.11 |
$21,845 |
I/I |
(1,356) |
410,403 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-28 |
4 |
AS |
$16.11 |
$115,348 |
D/D |
(7,160) |
2,169,680 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-27 |
4 |
AS |
$16.07 |
$2,153 |
I/I |
(134) |
411,759 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-27 |
4 |
AS |
$16.07 |
$11,361 |
D/D |
(707) |
2,176,840 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-13 |
4 |
AS |
$16.00 |
$1,024 |
I/I |
(64) |
411,893 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-13 |
4 |
AS |
$16.00 |
$5,376 |
D/D |
(336) |
2,177,547 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-07 |
4 |
AS |
$16.05 |
$8,619 |
I/I |
(537) |
411,957 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-07 |
4 |
AS |
$16.05 |
$45,598 |
D/D |
(2,841) |
2,177,883 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-06 |
4 |
AS |
$16.02 |
$9,580 |
I/I |
(598) |
412,494 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-09-06 |
4 |
AS |
$16.02 |
$50,687 |
D/D |
(3,164) |
2,180,724 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-08-23 |
4 |
S |
$16.00 |
$5,376 |
D/D |
(336) |
2,183,888 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
|
– – • |
2023-08-23 |
4 |
S |
$16.00 |
$1,024 |
I/I |
(64) |
413,092 |
0 |
% |
|
| ANTX |
An2 Therapeutics Ord Shs |
10% Owner |
– – • |
2022-06-06 |
4 |
A |
$15.00 |
$397,665 |
I/I |
26,511 |
413,156 |
0 |
- |
|
| ANTX |
An2 Therapeutics Ord Shs |
10% Owner |
– – • |
2022-06-06 |
4 |
D |
$15.00 |
$397,665 |
D/D |
(26,511) |
2,184,224 |
0 |
- |
|
| ANTX |
An2 Therapeutics Ord Shs |
10% Owner |
– – • |
2022-03-29 |
4/A |
B |
$15.00 |
$2,499,990 |
D/D |
166,666 |
2,210,735 |
2.45 |
- |
|
| ANTX |
An2 Therapeutics Ord Shs |
10% Owner |
– – • |
2022-03-29 |
4/A |
A |
$0.00 |
$0 |
I/I |
386,645 |
386,645 |
0 |
- |
|
| ANTX |
An2 Therapeutics Ord Shs |
10% Owner |
– – • |
2022-03-29 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,044,069 |
2,044,069 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
